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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYInduced pluripotent stem cell (iPSC) technology has been successfully used to recapitulate phenotypic traits of several human diseases
in vitro. Patient-specific iPSC-based disease models are also expected to reveal early functional phenotypes, although this remains to be
proved. Here, we generated iPSC lines from two patients with Sanfilippo type C syndrome, a lysosomal storage disorder with inheritable
progressive neurodegeneration. Mature neurons obtained from patient-specific iPSC lines recapitulated the main known phenotypes of
the disease, not present in genetically corrected patient-specific iPSC-derived cultures. Moreover, neuronal networks organized in vitro
frommature patient-derived neurons showed early defects in neuronal activity, network-wide degradation, and altered effective connec-
tivity. Our findings establish the importance of iPSC-based technology to identify early functional phenotypes, which can in turn shed
light on the pathological mechanisms occurring in Sanfilippo syndrome. This technology also has the potential to provide valuable read-
outs to screen compounds, which can prevent the onset of neurodegeneration.INTRODUCTION
Sanfilippo syndrome, also known as mucopolysaccharido-
sis type III (MPS III), is a lysosomal storage disorder (LSD)
with an autosomal recessive inheritance pattern. Four
different subtypes have been described (type A, OMIM
252900; type B, OMIM 252920; type C, OMIM 252930;
and type D,OMIM252940), which share clinical character-
istics, including severe early onset CNS degeneration that
typically results in death within the second or third decade
of life (Valstar et al., 2008). Each subtype is caused by mu-
tations in a different gene encoding for enzymes involved
in the degradation pathway of the glycosaminoglycan
(GAG) heparan sulfate (Neufeld and Muenzer, 2001). The
lack of activity of any of these enzymes leads to the accu-
mulation of partially degraded heparan sulfate chains
within the lysosomes. Subtype C (MPS IIIC) is caused by
mutations in the HGSNAT gene, encoding acetyl-CoA
a-glucosaminide N-acetyltransferase (EC 2.3.1.78), a lyso-
somal membrane enzyme. The prevalence of MPS IIIC
ranges between 0.07 and 0.42 per 100,000 births, depend-
ing on the population (Poupetova´ et al., 2010). The
HGSNAT gene was identified by two independent groups
in 2006 (Fan et al., 2006; Hrebı´cek et al., 2006), and 64546 Stem Cell Reports j Vol. 5 j 546–557 j October 13, 2015 j ª2015 The Adifferent mutations have been identified since then
(Human Gene Mutation Database Professional 2014.3). A
mouse model has been very recently developed (Martins
et al., 2015), but a cellular model for Sanfilippo type C
has yet to be developed.
The ability to reprogram somatic cells back to a pluripo-
tent state (Takahashi and Yamanaka, 2006; Takahashi
et al., 2007) has created new opportunities for generating
in vitro models of disease-relevant cells differentiated
from patient-specific induced pluripotent stem cell (iPSC)
lines (recently reviewed by Cherry and Daley, 2013; Inoue
et al., 2014; Trounson et al., 2012). This approach has been
shown to be particularly useful in the case of congenital or
early-onset monogenic diseases. In particular, iPSC-based
models of various LSD have been established, including
Gaucher disease (Mazzulli et al., 2011; Panicker et al.,
2012; Park et al., 2008; Scho¨ndorf et al., 2014; Tiscornia
et al., 2013), Hurler syndrome (Tolar et al., 2011), Pompe
disease (Higuchi et al., 2014; Huang et al., 2011), Sanfilippo
B syndrome (Lemonnier et al., 2011), and Niemann-Pick
type C1 (Maetzel et al., 2014; Trilck et al., 2013). In all these
cases, disease-relevant cell types derived from patient-spe-
cific iPSCs not only displayed morphologic, biochemical,
and/or functional hallmarks of the disease but also haveuthors
the capacity of being used as a drug-screening platform to
find therapies that are capable of reverting LSD-related
phenotypes.
In this study, we set out to test whether patient-specific
iPSC-derived cells could be used to investigate the existence
of early functional alterations prior to the appearance of
disease-related phenotypes identified in patients. For this
purpose, we generated iPSCs from fibroblasts of Sanfilippo
C syndrome patients (SFC-iPSCs) and differentiated them
into neurons, which recapitulate the pathological pheno-
types observed in vivo, such as low acetyl-CoA a-glucosa-
minide N-acetyltransferase activity, accumulation of
GAGs, and an increase in lysosome size and number. More-
over, we found that neural networks organized in vitro
from control iPSC-derived neurons grew in complexity
over time, as quantified in terms of neuronal activity,
network activity, and effective connectivity, a measure of
neuronal network function as defined by information the-
ory and analyzed through generalized transfer entropy
(GTE) methods. In contrast, networks of SFC-iPSC-derived
neurons showed early defects in neuronal activity and
alterations in effective connectivity and network organiza-
tion over time.
The identification of early functional phenotypes in
SFC-iPSC-derived neurons attests to the validity of iPSC-
based technology to model pre-symptomatic stages of
human diseases, thus widening the spectrum of potential
applications of somatic cell reprogramming for biomedical
research.RESULTS
Generation and Characterization of
Patient-Specific iPSCs
Fibroblasts from two unrelated Spanish patients with San-
filippo type C syndrome (SFC6 and SFC7) and two healthy
individuals (WT1 and WT2) were collected. Patient SFC6
was a compoundheterozygote carrying a splicingmutation
(c.633+1G > A) and a missense mutation (c.1334T > C;
p.L445P), both of which were found only in this patient
(Canals et al., 2011). This patient was also carrying the Rob-
ertsonian translocation der(13;14)(q10;q10), which is the
most common chromosome rearrangement in humans
and is usually phenotypically silent (Engels et al., 2008).
Patient SFC7 was a homozygote for themost prevalentmu-
tation in Spanish patients, accounting for 50% of the
mutated alleles (Canals et al., 2011), affecting another
splicing site (c.372-2A > G), which results in residual
enzyme activity (Matos et al., 2014) and a typically less se-
vere clinical progression. The effects of these mutations on
the splicing process and the transferase protein have been
previously described (Canals et al., 2011).Stem CellFibroblasts were reprogrammed at early passages (5–7)
through the retroviral delivery of SOX2, KLF4, and OCT4
(3F) or SOX2, KLF4, OCT4, and c-MYC (4F) to generate
up to 15 independent iPSC lines for each individual.
We selected clones displaying embryonic stem cell-like
morphology and positive alkaline phosphatase staining.
Four clones representing each individual were chosen to
be thoroughly characterized and shown to be fully reprog-
rammed, as judged by the silencing of the reprogramming
transgenes, activation of endogenous pluripotency-
associated factors, expression of pluripotency-associated
transcription factors and surface markers, demethylation
of OCT4 and NANOG promoters, pluripotent differentia-
tion ability in vitro and/or in vivo, and karyotype stability
after more than 15 passages (Figures 1A–1G and S1A–S1F;
Table S1).
Patient-Specific Neurons Recapitulate Known
Sanfilippo C Phenotypes
Wild-type (WT)- and SFC-iPSCs were then differentiated
to pure masses of neural precursors using a previously
described protocol (Cho et al., 2008) that involves the for-
mation of embryoid bodies and the culture of neural pre-
cursor cells to form spherical neural masses (SNMs), which
can be expanded and subsequently differentiated to
mature neurons after culturing them for several weeks in
neuronal induction medium (Figure 2A; see Supplemental
Experimental Procedures for further details). SNMs derived
from WT- and SFC-iPSC lines homogeneously expressed
neural progenitor markers such as PAX6, NESTIN, and
SOX2, as well as proliferation markers such as Ki67 (Fig-
ure S2). Furthermore, when iPSC-derived SNMs were
cultured in neuronal induction media supplemented with
N2 and B27, differentiation into mature and synaptically
active neurons was evident within 3 to 5 weeks (Figures
2B and 2C). After about 3 weeks in neuronal medium, the
cultures formed dense neuronal networks and stained for
dendritic marker MAP2 and synaptic marker SYNAPSIN.
Under these conditions, SNMs mainly generated MAP2-
positive mature neurons (63% ± 3% of differentiated cells,
mean ± SEM; n = 37), but also GFAP-positive cells (10% ±
1% of differentiated cells, mean ± SEM; n = 37), confirming
their neurogenic capacity (Figure 2B). MAP2-positive neu-
rons showed expression of SYNAPSIN, indicating their
capability to form synapses (Figure 2C).
Mutation analysis confirmed that SFC-iPSCs bore the
mutations present in the patients’ fibroblasts, resulting in
the expected splicing defects (data not shown). SFC-iPSCs
showed no detectable acetyl-CoA a-glucosaminide N-ace-
tyltransferase activity, consistent with the low enzyme
activity levels found in patients’ fibroblasts (1.78% and
3.02% of that of WT fibroblasts for SFC6 and SFC7, respec-
tively; Figure 3A). Similarly, SNMs and neural culturesReports j Vol. 5 j 546–557 j October 13, 2015 j ª2015 The Authors 547
Figure 1. Generation and Characterization of Control and SFC-iPSC Lines Using 3 Reprogramming Factors
A total of 17 independent iPSC lines were obtained after reprogramming control (WT1 and WT2) and SFC (SFC6 and SFC7) fibroblasts with
retroviruses expressing OCT4, SOX2, and KLF4. Two lines per fibroblast sample were selected for complete characterization: WT1-iPS#3.1,
WT1-iPS#3.6, WT2-iPS#3.1, WT2-iPS#3.2, SFC6-iPS#3.1, SFC6-iPS#3.2, SFC7-iPS#3.1, and SFC7-iPS#3.2. Shown are representative images
of the characterization of WT (WT1-iPS#3.6), SFC6 (SFC6-iPS#3.1), and SFC7 (SFC7-iPS#3.1) iPSC lines.
(A) Left: SFC fibroblasts before being transduced with retroviruses carrying reprogramming factors. The scale bar represents 50 mm. Center:
Typical human embryonic stem cell (hESC)-like colonies obtained after SFC fibroblast reprogramming. The scale bar represents 400 mm.
Right: Positive alkaline phosphatase staining of the hESC-like SFC-iPSC colonies. The scale bar represents 400 mm.
(B) Bisulfite genomic sequencing of the OCT4 and NANOG promoters showing demethylation pattern in WT-, SFC6-, and SFC7-iPSCs.
(C) RT-qPCR analyses of the expression levels of the indicated retroviral-derived reprogramming factors (TRANS-) and endogenous (ENDO-)
genes in WT-, SFC6- and SFC7-iPSC.
(D) Karyotype of WT-, SFC6-, and SFC7-iPSCs, which are identical to that of parent fibroblasts (including the known balanced Robertsonian
translocation der[13;14][q10;q10] of SFC6).(E) Representative colonies of WT-, SFC6-, and SFC7-iPSCs stained positive for the pluripo-
tency markers OCT4, SOX2, and NANOG (green) and SSEA3, SSEA4, and TRA-1-81 (red). The scale bar represents 100 mm.
(F) Immunofluorescence analyses with specific markers on WT-, SFC6-, and SFC7-iPSCs differentiated in vitro to generate cell derivatives of
all three primary germ layers. Endoderm, a-fetoprotein (green), FOX2A (red); mesoderm, GATA4 (green), a-SMA (red); and ectoderm, TUJ1
fetoprotein (green), GFAP (red). The scale bar represents 100 mm.
(G) Immunofluorescence analyses with specific markers on sections from the same teratoma induced after injecting WT-, SFC6-, or SFC7-
iPSCs, showing cell derivatives of the three embryo germ layers. Endoderm, a-fetoprotein (green), FOX2A (red); mesoderm, SOX9 (green),
CS (red); and ectoderm, TUJ1 fetoprotein (green), GFAP (red). The scale bar represents 100 mm.
See also Figure S1 and Table S1.derived from SFC-iPSCs showed low enzyme activity levels,
representing less than 1% of those found in control cells
(Figures 3C and 3D). Total GAG content in patients’ fibro-548 Stem Cell Reports j Vol. 5 j 546–557 j October 13, 2015 j ª2015 The Ablasts approximately doubled that of control cells (Fig-
ure 3E). In contrast, SFC-iPSC-derived neural cultures accu-
mulated GAG over time, reaching statistically significantuthors
Figure 2. Neural Differentiation of Con-
trol and SFC-Specific iPSC Lines
(A) Scheme illustrating the differentiation
protocol from iPSC to mature neurons
through the establishment of SNMs en-
riched in neural progenitors (NPs).
(B) Left images show immunofluorescence
analyses on representative neural differen-
tiation cultures from SNMs derived from
WT2-iPSC#3.1 (WT) and SFC7-iPSC#4.8 (SFC)
iPSC lines, stained for typical markers of
mature neurons (MAP2 in green) and as-
trocytes (GFAP in red). Central and right
images display the green and red channels
in white, for clarity. Similar results were
obtained from neural differentiation cul-
tures of SNMs derived from WT1-iPSC#3.1,
WT1-iPSC#3.6, WT1-iPSC#4.10, WT1-iPSC#4.12, WT2-iPSC#3.2, WT2-iPSC#4.2, WT2-iPSC#4.5, SFC6-iPSC#3.1, SFC6-iPSC#3.2, SFC6-
iPSC#4.6, SFC6-iPSC#4.7, SFC7-iPSC#3.1, SFC7-iPSC#3.2, and SFC7-iPSC#4.9 iPSC lines. The scale bar represents 50 mm.
(C) Representative image of the immunofluorescence analysis of a neuron differentiated from SNMs derived from the SFC7-iPSC#4.8 iPSC
line, stained with MAP2 (green), a mature neuronal marker, and SYNAPSIN (red), a marker for synapses (upper image). Magnification of a
neuron prolongation with specific staining for SYNAPSIN (lower image). Similar stainings were obtained from neural differentiation
cultures of SNMs derived from WT1-iPSC#3.1, WT1-iPSC#3.6, WT1-iPSC#4.10, WT1-iPSC#4.12, WT2-iPSC#3.1, WT2-iPSC#3.2, WT2-iPSC#4.2,
WT2-iPSC#4.5, SFC6-iPSC#3.1, SFC6-iPSC#3.2, SFC6-iPSC#4.6, SFC6-iPSC#4.7, SFC7-iPSC#3.1, SFC7-iPSC#3.2, and SFC7-iPSC#4.9 iPSC lines.
The scale bar represents 5 mm.
See also Figure S2.differences compared with controls only after 9 weeks of
culture (Figure 3F).
Gene-corrected controls were generated by lentiviral
(LV) complementation of SNMs with WT cDNA for the
HGSNAT gene under a cytomegalovirus (CMV) promoter
(LV.CMV.HGSNAT.ires.GFP; Figure S3A). The vector also
expressed GFP downstream of an internal ribosome entry
site element. Neural cells differentiated from gene-cor-
rected SNMs showed high activity of the enzyme, between
50- and 150-fold higher than those differentiated from
WT-SNMs transduced with a control LV.CMV.GFP vector
(Figures S3B–S3E), demonstrating long-term sustained
transgene expression. Gene complementation of SFC-
derived neural cultures prevented the statistically signifi-
cant accumulation of GAG observed in GFP-transduced
SCF cells after 9 weeks of differentiation, when compared
with control cells (Figure 3F).
Analysis by transmission electron microscopy (TEM) re-
vealed marked differences in lysosomes between controls
and patients, which increased along time. Whereas lyso-
somes for control cultures showed typical morphology
and size, we found only large vacuoles with an empty-like
appearance in patients’ samples (Figure 4A), similar to
those described in a mouse model of Sanfilippo B (Vitry
et al., 2010). These vacuoles were derived from lysosomes,
as judged by positive immuno-gold staining for LAMP1
(Figure 4B). The differences in lysosome size increased
with culture time and reached 80% for both patientsStem Cellcompared with controls at 9 weeks (Figure 4C). In addition,
immunostaining for LAMP2 in isolated neurons of these
cultures analyzed 9 weeks after differentiation showed sig-
nificant differences between controls and patients (Figures
4D and 4E), consistent with the 80% detected by the TEM
analysis, and illustrating that these differences can be
detected specifically in iPSC-derived neurons. After trans-
ductionwith theHGSNATcDNA, some cells presented lyso-
somes with a morphology between the affected type and
those of WT, suggesting a partial correction (Figure 4A).
Network-Broad Activity Alterations in Sanfilippo C
Neuronal Cultures
Next, we allowed control- and SFC-iPSC-derived neurons to
form networks and used a calcium fluorescence imaging
assay to monitor functional neuronal activity after 3, 6,
and 9 weeks. Typical recordings of spontaneous activity
at week 9 for the different conditions are shown in Movies
S1, S2, and S3. WT-iPSC-derived neurons showed repeated
firing episodes of large amplitude (‘‘bursts’’) that were not
present in SFC6-iPSC neurons. SFC7-iPSC neurons showed
a slightly richer activity than SFC6-iPSC neurons, but the
amplitude of the bursts was still low compared with WT-
iPSC neurons (Figure 5A). Gene complementation with
HGSNAT significantly changed the activity of the patient-
specific iPSC-derived neurons, and both SCF6- and SCF7-
iPSC-derived neurons exhibited activity patterns similar





Figure 3. HGSNAT Activity and GAG Storage in Control and SCF-Specific Cell Types
(A–D) Analyses of the HGSNAT enzyme activity expressed in nmol3 h13mg1 protein for the WT-, SFC6-, and SFC7-fibroblasts (A), iPSCs
(B), SNMs (C), and neurons (D). The data show mean ± SD of three independent experiments performed in triplicate (WT1, SFC6, and SFC7
fibroblasts and iPSCs, SNMs, and neurons derived from the WT1-iPSC#3.6, SFC6-iPSC#3.1, and SFC7-iPSC#3.1 iPSC lines), and three
independent experiments performed in duplicate (WT2 fibroblasts and iPSC, SNMs, and neurons derived from the WT1-iPSC#3.1, WT1-
iPSC#4.10, WT2-iPSC#3.1, WT2-iPSC#3.2, WT2-iPSC#4.2, WT2-iPSC#4.5, SFC6-iPSC#3.2, SFC6-iPSC#4.6, SFC6-iPSC#4.7, SFC7-iPSC#3.2,
SFC7-iPSC#4.8, and SFC7-iPSC#4.9 iPSC lines). **p < 0.01 (WT versus patients), ***p < 0.001 (WT versus patients).
(E) Analyses of the GAG levels expressed as percentage of WT levels, in WT1-, SFC6-, and SFC7-fibroblasts (E) and neurons differentiated for
3, 6, and 9 weeks from SNMs derived from the SFC6-iPSC#3.1 and SFC7-iPSC#3.1 iPSC lines or after 9 weeks from gene-complemented
(treated) SNMs derived from the SFC6-iPSC#3.1 and SFC7-iPSC#3.1 iPSC lines, relative to neurons differentiated at the same time points
from SNMs derived from the WT1-iPSC#3.6 iPSC line (F). The data show mean ± SD of three independent experiments performed in
duplicate. **p < 0.01 (WT versus patients).
See also Figure S3.The overall network performance was first quantified by
means of two standard descriptors: (1) neuronal activity,
which was defined as the average number of bursting epi-
sodes per neuron during the 30 min recording time, and
(2) fraction of active neurons, which was defined as the ra-
tio between those cells that showed at least one bursting
episode and the total population monitored (see detailed
definition and measurement in Experimental Procedures).
We first considered the scenario of cultures that were
not transduced to test the reliability of our analysis. The
network activity for WT cultures was close to 1, indicating
that most of the neurons in the network were active (Fig-
ure 5B). Activity wasmaintained within experimental error550 Stem Cell Reports j Vol. 5 j 546–557 j October 13, 2015 j ª2015 The Aat weeks 6 and 9. This stability of WT measurements al-
lowed us to associate possible changes in activity due solely
to the disorder. Indeed, neuronal activity in the patients’
neurons showed a gradual decrease, although the loss of ac-
tivity was more evident in networks of SFC6-iPSC-derived
neurons (Figure 5B).
We next considered the cultures that were transduced
by LV.CMV.GFP and LV.CMV.HGSNAT.ires.GFP and carried
out identical measurements (Figure 5C). For clarity, we
compared the relative change in activity of the cultures
from patients with respect to their WT counterparts
(namely, WT solely transduced with GFP or WT trans-
duced with both GFP and HGSNAT). We verified that WTuthors
Figure 4. Lysosome Alterations in SFC-
iPSC-Derived Neurons
(A) TEM micrograph representative of WT-,
SFC6-, SFC7-, and gene-complemented
SFC6-iPSC-derived neurons after 9 weeks of
differentiation, showing lysosomal-derived
accumulation vesicles (dark in the WT,
empty-like in both patients, and gray
in the gene-complemented sample). Neural
cultures for these experiments were
derived from SNMs established from the
WT1-iPSC#3.6, SFC6-iPSC#3.1, and SFC7-
iPSC#3.1 iPSC lines. The scale bar represents
2 mm.
(B) Immuno-gold analysis with anti-LAMP1
antibodies of SFC6-iPSC#3.1-derived neu-
rons after 9 weeks of differentiation
demonstrating the lysosomal origin of
accumulation vesicles (gold particles indi-
cated by black arrows). The scale bar repre-
sents 0.2 mm.
(C) Comparative analysis of lysosome size in WT, SFC6, and SFC7 samples, measured in TEM micrographs of fibroblasts and iPSC-derived
neurons at the indicated times of differentiation. Neurons were the most abundant cell type in these preparations and were readily
identified thanks to their round-shaped nuclei with weakly compacted chromatin and prominent nucleolus, scarce electrodense cytoplasm
with numerous organelles, and synaptic contacts. The values shown indicate the size of SFC6 and SFC7 lysosomes in each cell type relative
to the size of WT lysosomes in equivalent samples. The data show means ± SE of at least 200 lysosomes for each sample, obtained in 3
independent experiments. ***p < 0.001 (patients versus WT).
(D and E) Representative images of the immunoanalysis of LAMP2 staining per neuronal area in neurons (MAP2-positive cells) differ-
entiated from WT (line WT2-iPSC#3.1, left image) and SFC (line SFC7-iPSC#4.8, right image) iPSC lines (D) and comparative analysis
between control and patients at 9 weeks of differentiation (E). The values indicate the percentage of MAP2 stained area also stained for
LAMP2. The data show mean ± SE of at least 15 neurons for each sample, obtained in 3 independent experiments. **p < 0.01 (patients
versus controls).
See also Figure S4.GFP-transduced neurons showed the same trend as the un-
transduced ones within statistical error. SFC6 and SFC7
neuronal networks gradually decayed in activity, and at
week 9, activity loss reached about 70% and 45%, respec-
tively, compared with controls. The reproducibility of this
trend (evidenced by the small error bars and their similar
trends in Figures 5B and 5C) indicates that the transduction
protocol itself didnot influence thebehavior of theneurons
and the development of the network. On the other hand,
HGSNAT-transduced cultures showed a significant increase
in activity over time, reaching activity levels similar to con-
trols at 9 weeks (Figure 5C).
The analysis of the fraction of active neurons in the
network allowed further characterization of the differences
between the HGSNAT-treated and untreated cultures. As
shown in Figure 5D, GFP-only SFC6 and SFC7 exhibited
at week 9 about 70% and 50% less active neurons, respec-
tively, compared with WT controls. However, after trans-
duction with HGSNAT, both SFC6 and SFC7 maintained a
fraction of active neurons comparable with the WTs. We
also include in Figure 5E the values of network activity at
week 9 (corresponding to the time point of Figure 5C).Stem CellGFP-transduced SFC6 and SFC7 cultures showed a signifi-
cant loss of network activity, while the corresponding
HGSNAT-transduced counterparts reached activity levels
indistinguishable from the control condition.
Effective Connectivity Degradation in Patient-Specific
Neuronal Networks
Effective network connectivity was determined by identi-
fying causal influences among neurons through GTE, an
information theory method that allows drawing a func-
tional map of neuronal interactions in the network (Or-
landi et al., 2014; Stetter et al., 2012). A total of 30 cultures
were analyzed, extending from week 3 to 9, and including
all the conditions (WT, SFC, and gene-corrected SFC). Fig-
ure 6 provides the connectivity maps of three representa-
tive neuronal cultures at weeks 3 and 9, comparing the
WTand SFC7 casewith andwithoutHGSNAT transduction.
The WT and SFC7-HGSNAT-transduced cultures displayed
comparable network structures, where most of the
neurons established a similar pattern of connections with
other neurons including a uniform increase in connectiv-
ity. In contrast, in the GFP-only SFC7 cultures, strongReports j Vol. 5 j 546–557 j October 13, 2015 j ª2015 The Authors 551
Figure 5. Altered Neuronal Activity in
SFC-Derived Neuronal Networks
(A) Representative traces of spontaneous
neuronal activity at week 9 of differentia-
tion analyzed by calcium fluorescence im-
aging. Top traces correspond to control
(GFP-transduced) neuronal networks; bot-
tom traces correspond to gene com-
plemented (HGSNAT-transduced) networks.
Sharp increases in the fluorescence signal
denote bursting episodes. Firings events of
low amplitude (arrowheads) correspond to
single spikes.
(B) Neuronal activity (total number of
firings per neuron monitored along 30 min
recording) of three independent un-
transduced cultures, at 3, 6, and 9 weeks
after differentiation for each cell line and at
each time point.
(C) Relative change in activity of control
(GFP-transduced) or gene complemented
(HGSNAT-transduced) SFC6 and SFC7
neuronal networks with respect to their
equivalent WT networks. Three independent
cultures were analyzed for each cell line at
each time point.
(D) Fraction of active neurons at week 9 in control (GFP-transduced) or gene complemented (HGSNAT-transduced) WT, SFC6, and SFC7
neuronal networks. Three independent cultures were analyzed for each cell line at each time point.
(E) Neuronal activity of control (GFP-transduced) or gene complemented (HGSNAT-transduced) WT, SFC6, or SFC7 neuronal networks at
week 9 of differentiation. In (B) through (E), error bars are root-mean-square error. Three independent cultures were analyzed for each line
at each time point. *p < 0.05 (patients versus WT), **p < 0.01 (patients versus WT), #p < 0.05 (GFP- versus HGSNAT-transduced), ##p < 0.01
(GFP- versus HGSNAT-transduced).connections were formed only within a subset of neurons,
leaving most of the remaining neurons weakly connected
or disconnected, particularly at week 9. In general, from
the total of 30 cultures analyzed for network effective con-
nectivity, this extreme feature was almost exclusive to SFC6
and SFC7 cultures at week 9, with 4 of 6 cultures showing
such a trait. All 9 WTcultures at any week showed uniform
connectivity characteristics, and of the 15 HGSNAT-trans-
duced cultures analyzed, only 1 SFC6-transduced culture
at week 9 exhibited this extreme trait.
As a complementary measure of network connectivity,
we also analyzed the cultures for the existence of assortativ-
ity (Newman, 2002). A network is said to be assortative
when nodes with many connections preferentially con-
nect to one another. In turn, nodes with few connections
also tend to connect to one another. Conversely, a network
is said to be disassortative if nodes with many connections
tend to connect with nodes with few connections. In our
experiments, of a total of 30 analyzed cultures, 24 were as-
sortative and 6 disassortative. Interestingly, 4 of the disas-
sortative networks corresponded to the SFC6 and SFC7 cul-
tures at week 9 (see, e.g., Figure 6, bottom central panel).552 Stem Cell Reports j Vol. 5 j 546–557 j October 13, 2015 j ª2015 The AEach of the above analyses (i.e., the presence of uncon-
nected neurons and disassortativity traits) is not significant
when observed independently. However, their concurrent
presence is highly indicative of network-wide changes
in SFC6 and SFC7 untreated cultures compared with WT
andHGSNAT-transduced ones. Indeed, a combined Fisher’s
permutation test yields an achieved significance level (ASL)
of 0.02 between the SFC and WT cultures and an ASL of
0.03 between the SFC and SFC-HGSNAT transduced cul-
tures, whereas the ASL between SFC-HGSNAT and WT is
0.46, showing no statistically significant differences. The
reasonable significance of the former group supports the
idea that the disorder causes important network topology
changes, ultimately driving the affected networks toward
a state of high fragility.DISCUSSION
In this work, we have generated a neuronal model of
Sanfilippo type C by reprogramming fibroblasts from two
patients using the iPSC technology. The generation of authors
Figure 6. Alterations in Effective Con-
nectivity in SFC-Derived Neuronal Net-
works
Structure of representative WT and control
(GFP-transduced) or gene complemented
(HGSNAT-transduced) SFC7-iPSC-derived
neuronal networks at 3 (top) and 9
(bottom) weeks of differentiation, as re-
constructed through GTE methods. In all the
depicted networks, circles show the actual
position of the neurons in the culture and
are color-coded according to their relative
connectivity. For easier visualization,
the number of neurons in each network
is limited to 150, which are randomly
chosen from the original set, and only those
connections with p values < 0.002 are rep-
resented.neuronalmodel is relevant because themain features of the
disease cannot be studied in fibroblasts. The fact that we
used samples from two patients validates the results and al-
lows the detection of slight inter-individual differences,
although the study of additional Sanfilippo type C pa-
tient-specific iPSCs would be necessary to generalize our
conclusions.
iPSC technology has been widely used tomodel different
types of diseases, including those affecting the CNS (Dur-
naoglu et al., 2011; Okano and Yamanaka, 2014). Some
other LSDs have been modeled using iPSC technology,
which were later differentiated to the human cellular
type of interest for each case. For Pompe’s disease, cardio-
myocytes exhibit the highest accumulation of glycogen,
impaired autophagy, vacuolation, mitochondrial aber-
rances, and shorter survival times, features that were re-
verted after the overexpression of the normal gene (Huang
et al., 2011). In the case of Hurler disease, hematopoietic
and non-hematopoietic cells showed GAG accumulation
and could be rescued by introducing the normal copy of
the gene (Tolar et al., 2011). For Sanfilippo B syndrome, pa-
tient-derived neurons presented storage vesicles and Golgi
disorganization (Lemonnier et al., 2011). In the case of
Gaucher disease, iPSC-derived macrophages showed
impaired lysosomal function and red blood cell clearance,
recapitulating the hallmarks of the disease in this cell
type, which could be reverted after administration of the
recombinant enzyme (Panicker et al., 2012). Moreover,
Gaucher disease-specific macrophages and neurons dis-
played low enzyme activity that could be partially rescued
using small compounds with chaperone activity (TiscorniaStem Cellet al., 2013); and dopaminergic neurons accumulated glu-
cosylceramide and a-synuclein and showed autophagy
and lysosomal defects and dysregulation of calcium ho-
meostasis, all of which could be reverted after gene correc-
tion (Scho¨ndorf et al., 2014). Finally, for Niemann-Pick
type C1, iPSC-derived neurons exhibited spontaneous ac-
tion potentials, confirming their maturation and accumu-
lated cholesterol (Trilck et al., 2013). In another work
regarding this disease, hepatic and neuronal cells presented
lower cell viability, cholesterol storage, and impaired auto-
phagy, features that could be reverted after gene correction
(Maetzel et al., 2014). In many of these studies, the pheno-
types observed could not be analyzed in fibroblasts, high-
lighting the importance of developing iPSC-derived
models. Gene complementation provides an important
experimental control that allows the assurance that the
phenotypes detected are due to the genetic defect in the pa-
tient, rather than reprogramming artifacts.
In the present study, enzyme activity was dispensable for
reprogramming and iPSC maintenance. This is in contrast
with Fanconi anemia (Raya et al., 2009; Navarro et al.,
2014), and also with Sanfilippo type B (Lemonnier et al.,
2011) and Pompe disease (Higuchi et al., 2014), in all of
which gene complementation was needed to achieve re-
programming. We hypothesize that the dispensability of
enzyme activity for iPSC generation and maintenance
might be related to overall low lysosomal activity in these
cells. Thus, all the iPSCs generated in the present study
(from either controls or SFC patients) showed relatively
small numbers of lysosomes in comparison with fibro-
blasts, as judged by immunostaining with LAMP2Reports j Vol. 5 j 546–557 j October 13, 2015 j ª2015 The Authors 553
(Figure S4). Moreover, enzyme activity was very low in con-
trol iPSCs compared with fibroblasts (Figures 3A and 3B), as
were the activities of other lysosomal enzymes (b-hexosa-
minidase and b-glucocerebrosidase; data not shown), in
agreement with previous results (Tiscornia et al., 2013).
Taken together, all these data suggest that iPSCs present a
small number of lysosomes in comparison with other cell
types.
To reduce the variability associated with neural differen-
tiation of iPSCs (Falk et al., 2012), we established iPSC-
derived SNMs consisting of neural progenitor cells that
can be expanded and subsequently differentiated to neu-
rons and glia (Cho et al., 2008). Mature human neurons
that exhibit the principal features of the disease have
been successfully generated after culturing iPSC-derived
neural precursors cells for 3 to 9weeks in neuronal differen-
tiation medium. iPSC differentiation, including mature
and functional neurons as the main cellular type, was
proved through the expression ofmature neuronalmarkers
as well as synaptic proteins. Importantly, neuronal cultures
derived from SFC patients showed lack of enzyme activity
and an accumulation of GAGs and alteration of lysosomes.
Apart from the lack of enzyme activity, which is always
lacking in SFC cultures, other alterations appeared to be
progressive. GAGs accumulated over time, but in our exper-
iments, these differences did not reach statistical signifi-
cance versus controls until 9 weeks (around 50% respect
to control), which could indicate a lower rate of synthesis
and storage in this cell type compared to fibroblasts. Lyso-
somal alterations displayed through TEM/LAMP1 and im-
munostainingwith LAMP2were first noticed at 3 to 6weeks
and became dramatic at 9 weeks (almost doubled in size).
This timeline of appearance of alterations is in concor-
dance with the progressive nature of the disease and high-
lights current difficulties in predicting the extent of neuro-
logical decline, because the lack of enzyme activity is not
predictive, and the analysis of GAG storage and lysosome
size and number requires invasive techniques.
The fact that our SFC-iPSC-derived neural cultures devel-
oped alterations that recapitulated those seen in patients
prompted us to investigate whether we could detect early
functional alterations predating known pathological signs
of the disease. For this purpose, we used calcium imaging to
analyze neuronal function in patients’ cells. An important
decrease in spontaneous activity of SFC neurons compared
with WT controls was already detected at 3 weeks of differ-
entiation, particularly for the most severe case (SFC6). The
different behavior in SFC6 and SFC7 could be due to the
particular features of their mutations. In this regard, we
have recently showed that the c.372-2G > A mutation,
borne by SFC7, gives rise to a protein lacking 4 amino acids
that has some residual activity (Matos et al., 2014). These
data suggest that the decline of neuronal activity correlates554 Stem Cell Reports j Vol. 5 j 546–557 j October 13, 2015 j ª2015 The Awith the severity of the neurological phenotype observed
in patients.
Moreover, we combined a direct quantification of
neuronal activity with advanced functional connectivity
analyses framed in the context of transfer entropy (TE)
(Stetter et al., 2012). The latter provided evidences for
broad changes in network structure, unraveling extensive
disconnection of neurons, the emergence of a subset of
highly connected cells, and the evolution of the network
toward a disassortative structure. Although the presence
of unconnected neurons is a clear indicator of a dysfunc-
tional network, the existence of assortative or disassorta-
tive traits is not. Indeed, several naturally occurring
networks may fall into one kind or another (Honey et al.,
2007; Pan et al., 2010). Theoretical studies (Schmeltzer
et al., 2014) and experiments in vitro (Teller et al., 2014)
have shown that assortative networks are resilient to attack
since the highly connected nodes shape a core that pre-
serves the functionality of network. In contrast, disassorta-
tive networks are highly vulnerable, since the targeted loss
of the few highly connected nodes may cause network-
wide failure (Newman, 2002). These ideas, translated to
our study, suggest that the affected, disassortative cultures
could completely collapse upon such targeted damage,
making them highly vulnerable networks.
Our results and analyses suggest that the disorder
notably disrupts the topology of the network. In the
context of the patients, these alterations could significantly
affect the normal operation of the brain. Such an aspect is
important in the framework of studies that highlight the
relation between altered network topology upon disease
and the degradation of brain’s operability and cognitive
tasks (Bassett and Bullmore, 2009; van den Heuvel and
Sporns, 2013).
The spontaneous activity of SFC-derived neurons was
recovered after transduction, in the SNM stage, with lenti-
viruses carrying the WT HGSNAT cDNA, and subsequent
differentiation. The lack of recovery at 3 weeks and the par-
tial recovery at 6 weeks contrast with the total recovery at
9 weeks of differentiation. We believe these differences
are due to the fact that LV transduction was around 60%
efficient, which could initially slow down the development
of the network compared with the WT case. At later stages,
we hypothesize that the large fraction of healthy neurons
suffices to foster broad circuit connectivity and, ultimately,
high neuronal activity. We note that the high expression
levels of the transduced cells do not seem to alter their in-
dividual activity. Indeed, the WT-derived cultures overex-
pressing the HGSNAT cDNA did not show any significant
alteration in these properties. However, our results indicate
that the transduced cells do play a role in maintaining
or restoring broad network activity and connectivity.
Thus, we conclude that neuronal network activity anduthors
development could be reestablished with a therapeutic
approach that rescues only a fraction (though sufficiently
high) of the total neurons. However, GAG storage or lyso-
some appearance by TEM showed only partial reversion
after 9 weeks of differentiation. Whether longer times are
needed for complete reversion of these features, or whether
this is not at all possible, will require further investigation.
The availability of the human cellularmodel described here
provides an excellent tool to investigate this and other
issues.
In summary, the cellular model introduced here
reproduces the major features of the Sanfilippo type
C syndrome, especially specific neuronal traits. We have
demonstrated that most of the phenotypic features of
this neuronal model can be reversed after gene comple-
mentation, using lentiviruses overexpressing the cDNA of
the HGSNAT gene. Moreover, our neuronal model could
be used as a tool to test different possible therapeutic stra-
tegies. This is particularly relevant because no cellular
model was available for Sanfilippo type C syndrome, and
a mouse model has only very recently been developed
(Martins et al., 2015). Our findings prove the usefulness
of iPSC-derived neuronal models to detect early functional
phenotypes that can shed light onto the molecular and
cellular processes that lead to the brain dysfunction in
these patients, as well as providing valuable readouts for
screening of potential therapeutic compounds that pre-
vent, rather than revert, the onset of neurodegeneration.
Moreover, the neuronal activity and effective connectivity
analyses could be applicable to other neurodegenerative
diseases in which iPSC-based models are available, such
as Parkinson’s or Alzheimer’s disease, autism, and others.
Further studies are needed to establish whether this tech-
nique would be able to detect differences in the neuronal
activity or the network structure before the onset of disease.
Such an approach could foster the development of in vivo
analyses for early diagnosis of patients affected by neuro-
logical diseases, as well as their monitoring during poten-
tial treatments.EXPERIMENTAL PROCEDURES
A complete description of experimental procedures can be found
in Supplemental Experimental Procedures.Network Reconstruction
Network reconstructionwas carried out by identifying causal influ-
ences between neurons through TE (Schreiber, 2000; Stetter et al.,
2012; Vicente et al., 2011). TE is an information-theoretic measure
that identifies the flow of information between two time traces.
The measure is model free (i.e., it does not require previous knowl-
edge of the dynamics of the system) and is able to detect linear and
non-linear interactions between any pair of traces. In a moreStem Cellformal description of TE, one considers two signals X and Y (any
two neuronal fluorescence traces in our case), with the goal to
assess the influence of X on Y (X/ Y). TE measures the amount
of uncertainty reduced in predicting the future of Y by taking
into account both the pasts of Y and X, rather than the past of Y
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whereas P($j$) is the conditional probability. The sum is performed





There are different variations of the TE measure depending on
the data under analysis, for example, fMRI (Honey et al., 2007),
magnetoencephalography (Wibral et al., 2011), spike trains (Ito
et al., 2011), or fluorescence data, as in our case. Here we use a
version named GTE (Orlandi et al., 2014; Stetter et al., 2012) that
was specifically developed for neuronal fluorescence signals (see
Stetter et al., 2012, for details).
The analysis of the recorded spontaneous activity traces within
the context of GTE was as follows. We initially computed the first
derivative of the fluorescence trace and the resulting values binned
with n = 2 intervals for TE computation. TE was then applied to all
pairs of neurons in the network. TE assigns a score for every
neuronal pair, but only those pairs with scores above a given signif-
icance level were considered putative connections. Significance
was established by comparing the raw TE scores and the bootstrap-
ped versions (to account for bias) and those obtained by shuffling
the data from only the presynaptic neuron. Bootstrapped versions
were obtained by generating surrogates of the fluorescence data for
every neuronal pair while preserving temporal correlations be-
tween the pairs. For the representative networks, a paired Z test
was performed with the bias-corrected and shuffled scores, and
only those values above the 97.5th percentile (p < 0.002) were
considered putative connections. For the connectivity and assorta-
tivity analysis, only the connections with the top 10% bias-cor-
rected score were considered.
Statistical Analysis
Differences between conditions respect to controls were evaluated
using a Mann-Whitney non-parametric U test, and statistical sig-
nificance was set at p < 0.05, except for the network reconstruction
experiment (see above).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, three tables, and three movies and can
be found with this article online at http://dx.doi.org/10.1016/j.
stemcr.2015.08.016.
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